Shimura T, Yin C, Ma R, Zhang A, Nagai Y, Shiratori A
Oncol Lett. 2025; 29(3):144.
PMID: 39850719
PMC: 11755263.
DOI: 10.3892/ol.2025.14890.
Yang J, Li C, Wang Z, Jiang K
Funct Integr Genomics. 2024; 24(6):210.
PMID: 39527375
PMC: 11554882.
DOI: 10.1007/s10142-024-01493-x.
Wang M, Zao X, Ge Z, Fan X, Jin L, Zhang J
Oncol Lett. 2024; 28(4):497.
PMID: 39211303
PMC: 11358718.
DOI: 10.3892/ol.2024.14630.
Goncalves J, Amaral J, Capela R, Perry M, Braga C, Gaspar M
Cell Death Discov. 2024; 10(1):261.
PMID: 38806468
PMC: 11133381.
DOI: 10.1038/s41420-024-02033-z.
Wang L, Dong X, Yu M, Nie X, Du M, Zhao X
Am J Transl Res. 2024; 16(1):216-223.
PMID: 38322560
PMC: 10839376.
Poly(d,l-lactide--glycolide) Surface-Anchored Biotin-Loaded Irinotecan Nanoparticles for Active Targeting of Colon Cancer.
Giram P, Nimma R, Bulbule A, Yadav A, Gorain M, Venkata Radharani N
ACS Omega. 2024; 9(3):3807-3826.
PMID: 38284072
PMC: 10809773.
DOI: 10.1021/acsomega.3c07833.
Cancer Treatment Closer to the Patient Reduces Travel Burden, Time Toxicity, and Improves Patient Satisfaction, Results of 546 Consecutive Patients in a Northern Italian District.
Cavanna L, Citterio C, Mordenti P, Proietto M, Bosi C, Vecchia S
Medicina (Kaunas). 2023; 59(12).
PMID: 38138224
PMC: 10744793.
DOI: 10.3390/medicina59122121.
Overview of the New Bioactive Heterocycles as Targeting Topoisomerase Inhibitors Useful Against Colon Cancer.
Santos M, de Azevedo Teotonio Cavalcanti M, de Medeiros E Silva Y, Nascimento I, Olimpio de Moura R
Anticancer Agents Med Chem. 2023; 24(4):236-262.
PMID: 38038012
DOI: 10.2174/0118715206269722231121173311.
study of miRNA-369-3p targeting TCF4 regulating the malignant biological behavior of colon cancer cells.
Li Y, Sun J, Granados-Lopez A, Chu Z, Zhang H
J Gastrointest Oncol. 2023; 14(5):2124-2133.
PMID: 37969834
PMC: 10643592.
DOI: 10.21037/jgo-23-628.
Clinical plasma cells-related genes to aid therapy in colon cancer.
Zhang Q, Feng X, Zhang M, Sun W, Zhai Y, Qing S
BMC Genomics. 2023; 24(1):430.
PMID: 37528394
PMC: 10391883.
DOI: 10.1186/s12864-023-09481-4.
E2F3 accelerates the stemness of colon cancer cells by activating the STAT3 pathway.
Gao Q, An K, Lv Z, Wang Y, Ding C, Huang W
Front Oncol. 2023; 13:1203712.
PMID: 37456248
PMC: 10346838.
DOI: 10.3389/fonc.2023.1203712.
MTA1, a Novel ATP Synthase Complex Modulator, Enhances Colon Cancer Liver Metastasis by Driving Mitochondrial Metabolism Reprogramming.
Wang T, Sun F, Li C, Nan P, Song Y, Wan X
Adv Sci (Weinh). 2023; 10(25):e2300756.
PMID: 37442756
PMC: 10477900.
DOI: 10.1002/advs.202300756.
Aptamer functionalized nucleic acid nano drug for targeted synergistic therapy for colon cancer.
Zhu L, Yuhan J, Yu H, Zhang B, Zhu L, He X
J Nanobiotechnology. 2023; 21(1):182.
PMID: 37280622
PMC: 10245494.
DOI: 10.1186/s12951-023-01941-z.
Music Therapy: A Noninvasive Treatment to Reduce Anxiety and Pain of Colorectal Cancer Patients-A Systemic Literature Review.
Huang E, Huang J
Medicina (Kaunas). 2023; 59(3).
PMID: 36984483
PMC: 10051791.
DOI: 10.3390/medicina59030482.
Promising antitumor effects of the curcumin analog DMC-BH on colorectal cancer cells.
Liu G, Chen J, Bao Z
Aging (Albany NY). 2023; 15(6):2221-2236.
PMID: 36971681
PMC: 10085616.
DOI: 10.18632/aging.204610.
Polysaccharide Peptide Induced Colorectal Cancer Cells Apoptosis by Down-Regulating and Expression.
Jian L, Zhicheng H, Shubai L
Iran J Pharm Res. 2023; 21(1):e123909.
PMID: 36942063
PMC: 10024323.
DOI: 10.5812/ijpr-123909.
Effect of a Combined Drug Approach on the Severity of Ischemia-Reperfusion Injury During Liver Transplant: A Randomized Clinical Trial.
Meurisse N, Mertens M, Fieuws S, Gilbo N, Jochmans I, Pirenne J
JAMA Netw Open. 2023; 6(2):e230819.
PMID: 36853611
PMC: 9975910.
DOI: 10.1001/jamanetworkopen.2023.0819.
The Impact of Bevacizumab and Chemotherapy on Quality of Life in Metastatic Colorectal Cancer Patients.
Moisuc D, Marinca M, Matei A, Popovici L, Cianga P
Healthcare (Basel). 2023; 11(4).
PMID: 36833125
PMC: 9956224.
DOI: 10.3390/healthcare11040591.
Increased expression of GIPC2 in colon adenocarcinoma is associated with a favorable prognosis and high levels of immune cell infiltration.
Kang M, Su Z
Oncol Rep. 2023; 49(4).
PMID: 36799193
PMC: 9996678.
DOI: 10.3892/or.2023.8503.
Development of lactate-related gene signature and prediction of overall survival and chemosensitivity in patients with colorectal cancer.
Tong Z, Wang X, Shi S, Hou T, Gao G, Li D
Cancer Med. 2023; 12(8):10105-10122.
PMID: 36776001
PMC: 10166923.
DOI: 10.1002/cam4.5682.